Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature

Abstract Cefiderocol is a new siderophore cephalosporin with activity against carbapenem-resistant gram-negative bacteria. Data on its clinical efficacy are limited to complicated urinary tract infections. We present a series of 3 patients successfully treated with cefiderocol for complicated health...

Full description

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2020-06, Vol.7 (6), p.ofaa185-ofaa185
Main Authors: Zingg, Sandra, Nicoletti, G Jacopo, Kuster, Sabine, Junker, Milena, Widmer, Andreas, Egli, Adrian, Hinic, Vladimira, Sendi, Parham, Battegay, Manuel, Bättig, Veronika, Khanna, Nina, Tschudin-Sutter, Sarah
Format: Article
Language:English
Subjects:
Brief Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Cefiderocol is a new siderophore cephalosporin with activity against carbapenem-resistant gram-negative bacteria. Data on its clinical efficacy are limited to complicated urinary tract infections. We present a series of 3 patients successfully treated with cefiderocol for complicated health care–associated infections and review published case reports.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofaa185